MRC1 and neoplasm: This analysis showed an overall decrease in the percentage of monocyte subpopulations expressing CD206 or CD274, as well as in the expression of these markers (MFI) in the blood samples, either from CRCLM or control (CTR), when compared to the tissue samples (non-tumor or tumor) from CRCLM patients (Figure 5a–l).